HK1153196A1 - Bridged heterocyclic compounds and methods of use - Google Patents
Bridged heterocyclic compounds and methods of useInfo
- Publication number
- HK1153196A1 HK1153196A1 HK11107367.7A HK11107367A HK1153196A1 HK 1153196 A1 HK1153196 A1 HK 1153196A1 HK 11107367 A HK11107367 A HK 11107367A HK 1153196 A1 HK1153196 A1 HK 1153196A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- heterocyclic compounds
- bridged heterocyclic
- bridged
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3905808P | 2008-03-24 | 2008-03-24 | |
US14505809P | 2009-01-15 | 2009-01-15 | |
PCT/US2009/038142 WO2009120720A1 (en) | 2008-03-24 | 2009-03-24 | Bridged heterocyclic compounds and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1153196A1 true HK1153196A1 (en) | 2012-03-23 |
Family
ID=40651664
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11107367.7A HK1153196A1 (en) | 2008-03-24 | 2011-07-15 | Bridged heterocyclic compounds and methods of use |
HK11111872.7A HK1157751A1 (en) | 2008-03-24 | 2011-11-03 | Bridged heterocyclic compounds and methods of use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11111872.7A HK1157751A1 (en) | 2008-03-24 | 2011-11-03 | Bridged heterocyclic compounds and methods of use |
Country Status (13)
Country | Link |
---|---|
US (4) | US8546381B2 (de) |
EP (1) | EP2274307B1 (de) |
JP (2) | JP5586577B2 (de) |
CN (1) | CN102046625B (de) |
AR (1) | AR071284A1 (de) |
AU (1) | AU2009228401B2 (de) |
BR (1) | BRPI0906245A2 (de) |
CA (1) | CA2718790A1 (de) |
CL (1) | CL2009000725A1 (de) |
HK (2) | HK1153196A1 (de) |
PE (1) | PE20091820A1 (de) |
TW (1) | TWI450900B (de) |
WO (1) | WO2009120720A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
RU2544856C2 (ru) | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
PE20091820A1 (es) | 2008-03-24 | 2009-12-10 | Medivation Technologies Inc | Compuestos heterociclicos con uniones puente y metodos para usarlos |
EP2280968A2 (de) | 2008-03-24 | 2011-02-09 | Medivation Technologies, Inc. | Pyrido[3,4-b]indole und anwendungsverfahren |
JP2012504137A (ja) | 2008-09-29 | 2012-02-16 | アボット・ラボラトリーズ | インドール誘導体およびインドリン誘導体ならびにそれらの使用方法 |
US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
US8569287B2 (en) | 2008-10-31 | 2013-10-29 | Medivation Technologies, Inc. | Azepino[4,5-B]indoles and methods of use |
TWI477503B (zh) | 2008-10-31 | 2015-03-21 | Medivation Technologies Inc | 含有剛性部分之吡啶并〔4,3-b〕吲哚 |
KR20110132564A (ko) | 2009-02-11 | 2011-12-08 | 선오비온 파마슈티컬스 인코포레이티드 | 히스타민 h3 역 작용제 및 길항제, 및 이의 사용 방법 |
CN102480956B (zh) | 2009-04-29 | 2015-04-08 | 梅迪维新技术公司 | 吡啶并[4,3-b]吲哚类和使用方法 |
WO2010127177A1 (en) | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
EP2475662A2 (de) * | 2009-09-11 | 2012-07-18 | Sunovion Pharmaceuticals Inc. | Inverse histamin-h3-agonisten und antagonisten sowie anwendungsverfahren dafür |
BR112012006648A2 (pt) * | 2009-09-23 | 2019-09-24 | Medivation Neurology Inc | composto,método de tratamento de um distúrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal, composição farmacêutica e kit |
BR112012006646A2 (pt) | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | composto, composição farmacêutica, método de tratamento de um distùrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit |
BR112012006640A2 (pt) | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | composto, composição farmacêutica, método de tratamento de um distúrbio cognitivo, distúrbiopsocótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit |
US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
US8524703B2 (en) | 2009-12-17 | 2013-09-03 | Abbvie Inc. | Bridgehead amine ring-fused indoles and indolines |
WO2011084433A2 (en) * | 2009-12-17 | 2011-07-14 | Abbott Laboratories | Aza-bridged ring-fused indoles and indolines |
US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9034865B2 (en) | 2010-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9187471B2 (en) | 2010-02-19 | 2015-11-17 | Medivation Technologies, Inc. | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
WO2012099952A2 (en) | 2011-01-19 | 2012-07-26 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
WO2012112961A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating hypertension |
WO2012112962A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
US8815843B2 (en) | 2011-02-18 | 2014-08-26 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
US9035056B2 (en) | 2011-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
RU2490268C2 (ru) * | 2011-11-10 | 2013-08-20 | Федеральное Государственное Бюджетное Учреждение Науки Институт Физиологически Активных Веществ Российской Академии Наук (Ифав Ран) | ХЛОРГИДРАТЫ ФТОРСОДЕРЖАЩИХ ЗАМЕЩЕННЫХ 5-[2-(ПИРИД-3-ИЛ)-ЭТИЛ]-2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛОВ, В КАЧЕСТВЕ СРЕДСТВ СНИЖЕНИЯ НЕКОНТРОЛИРУЕМОЙ АГРЕГАЦИИ БЕЛКОВ В НЕРВНОЙ СИСТЕМЕ, ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ИХ ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
WO2013177241A1 (en) | 2012-05-22 | 2013-11-28 | Trustees Of Dartmouth College | Method for synthesizing cycloalkanyl(b}indoles, cycloalkanyl(b) benzofurans, cycloalkanyl(b)benzothiophenes, compounds and methods of use |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4360673A (en) * | 1980-03-31 | 1982-11-23 | Schering Corporation | 5 Phenyl-1,3-alkano-1,2,3,4,4a,9b-hexahydropyrido [4,3-b]indoles |
US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
US5250537A (en) * | 1992-03-13 | 1993-10-05 | Scios Nova Inc. | 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives |
RU2106864C1 (ru) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
US6251893B1 (en) * | 1998-06-15 | 2001-06-26 | Nps Allelix Corp. | Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
US20040041081A1 (en) | 2002-08-30 | 2004-03-04 | Feldman Michael R. | Integrated optical transceiver and related methods |
JPWO2002037480A1 (ja) | 2000-10-26 | 2004-03-11 | 株式会社日立製作所 | 磁気ヘッドスライダ及び磁気ディスク装置 |
US20040077261A1 (en) | 2002-02-11 | 2004-04-22 | Fitzgerald David J. | Children's toy waterslide |
DE10325738B3 (de) | 2003-06-06 | 2004-12-02 | Atlas Elektronik Gmbh | Verfahren zur Generierung eines dreidimensionalen Geländemodells |
US7736889B2 (en) | 2003-06-10 | 2010-06-15 | The United States Of America As Represented By The Secretary Of The Navy | Fluidic force discrimination |
US20070179174A1 (en) | 2003-12-08 | 2007-08-02 | Bachurin Sergei O | Methods and compositions for slowing aging |
RU2283108C2 (ru) | 2003-12-08 | 2006-09-10 | Сергей Олегович Бачурин | ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
DE102005017477A1 (de) | 2005-02-18 | 2006-08-31 | Tecpharma Licensing Ag | Feder in einem oder für ein Injektionsgerät |
JP4408842B2 (ja) | 2005-06-30 | 2010-02-03 | 株式会社リコー | シート搬送装置、自動原稿搬送装置、給紙装置および画像形成装置 |
KR100933426B1 (ko) | 2005-07-21 | 2009-12-23 | 주식회사 엘지화학 | 가변성 전지 카트리지 및 그것으로 구성된 중대형 전지모듈 |
KR100806812B1 (ko) | 2005-07-25 | 2008-02-25 | 엘지.필립스 엘시디 주식회사 | 유기 el 소자 및 그 제조방법 |
US20070022645A1 (en) | 2005-07-29 | 2007-02-01 | Villarin Luna H | Magnetic display holder |
US20070024626A1 (en) | 2005-07-29 | 2007-02-01 | Microsoft Corporation | Large character set handling in limited devices |
US20110178119A1 (en) * | 2005-08-19 | 2011-07-21 | Elan Pharmaceuticals, Inc. | Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase |
WO2007041697A2 (en) | 2005-10-04 | 2007-04-12 | Medivation, Inc. | Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease |
RU2338537C2 (ru) | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
US7768963B2 (en) | 2006-07-07 | 2010-08-03 | Skyhook Wireless, Inc. | System and method of improving sampling of WLAN packet information to improve estimates of Doppler frequency of a WLAN positioning device |
DE102006031693A1 (de) | 2006-07-08 | 2008-01-17 | Magna Car Top Systems Gmbh | Tragvorrichtung für ein Fahrrad |
JP2010504338A (ja) | 2006-09-20 | 2010-02-12 | メディベイション ニューロロジー, インコーポレイテッド | 筋萎縮性側索硬化症(ALS)の治療のための水素化ピリド[4,3−b]インドール |
JP2010504337A (ja) | 2006-09-20 | 2010-02-12 | メディベイション ニューロロジー, インコーポレイテッド | イヌの認知機能障害症候群の治療のためのディメボン(dimebon)などの水素化ピリド[4,3−b]インドール |
EP2420235A1 (de) | 2006-10-27 | 2012-02-22 | Medivation Neurology, Inc. | Verfahren und Kombinationstherapien zur Behandlung von Alzheimer |
RU2329044C1 (ru) | 2006-11-16 | 2008-07-20 | Андрей Александрович Иващенко | Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство |
RU2334514C1 (ru) | 2006-12-01 | 2008-09-27 | Институт физиологически активных веществ Российской Академии наук | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
RU2340342C2 (ru) | 2006-12-07 | 2008-12-10 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И ХРОНИЧЕСКИХ НАРУШЕНИЙ МОЗГОВОГО КРОВООБРАЩЕНИЯ, В ТОМ ЧИСЛЕ ИНСУЛЬТА, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО[4,3-b]ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
RU2338745C1 (ru) | 2007-03-21 | 2008-11-20 | Андрей Александрович Иващенко | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
RU2339637C1 (ru) | 2007-04-05 | 2008-11-27 | Андрей Александрович Иващенко | Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием |
UA98324C2 (ru) | 2007-04-05 | 2012-05-10 | Андрей Александрович Иващенко | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
US20100178277A1 (en) | 2007-05-25 | 2010-07-15 | Medivation Neurology, Inc. | Methods and compositions for stimulating cells |
RU2338533C1 (ru) | 2007-06-28 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО, ОБЛАДАЮЩЕЕ АНКСИОЛИТИЧЕСКИМ ДЕЙСТВИЕМ, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
CA2719824A1 (en) | 2007-08-01 | 2009-02-05 | Medivation Neurology, Inc. | Methods and compositions for treating schizophrenia using antipsychotic combination therapy |
WO2009039420A1 (en) | 2007-09-21 | 2009-03-26 | Medivation Neurology, Inc. | Methods and compositions for treating neuronal death mediated ocular diseases |
RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
WO2009082268A2 (ru) | 2007-12-21 | 2009-07-02 | Alla Chem, Llc | ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ |
RU2544856C2 (ru) * | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
WO2009111540A1 (en) | 2008-03-04 | 2009-09-11 | Medivation Neurology, Inc. | Methods for preparing pyridylethyl-substituted carbolines |
EP2280968A2 (de) | 2008-03-24 | 2011-02-09 | Medivation Technologies, Inc. | Pyrido[3,4-b]indole und anwendungsverfahren |
PE20091820A1 (es) | 2008-03-24 | 2009-12-10 | Medivation Technologies Inc | Compuestos heterociclicos con uniones puente y metodos para usarlos |
KR101615505B1 (ko) | 2008-03-27 | 2016-04-26 | 그뤼넨탈 게엠베하 | 치환된 스피로사이클릭 사이클로헥산 유도체 |
WO2009135091A1 (en) | 2008-04-30 | 2009-11-05 | Medivation Technologies, Inc. | Use of asenapine and related compounds for the treatment of neuronal or non-neuronal diseases or conditions |
US20100029706A1 (en) | 2008-07-30 | 2010-02-04 | Edison Parmaceuticals, Inc. a Delaware Corporation | HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS |
US9625475B2 (en) * | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
JP2012504137A (ja) * | 2008-09-29 | 2012-02-16 | アボット・ラボラトリーズ | インドール誘導体およびインドリン誘導体ならびにそれらの使用方法 |
TWI477503B (zh) | 2008-10-31 | 2015-03-21 | Medivation Technologies Inc | 含有剛性部分之吡啶并〔4,3-b〕吲哚 |
US8569287B2 (en) | 2008-10-31 | 2013-10-29 | Medivation Technologies, Inc. | Azepino[4,5-B]indoles and methods of use |
US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
WO2010081115A1 (en) | 2009-01-09 | 2010-07-15 | University Of Texas Southwestern Medical Center | Pro-neurogenic compounds |
US9962368B2 (en) | 2009-01-09 | 2018-05-08 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
WO2010127177A1 (en) | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
CN102480956B (zh) | 2009-04-29 | 2015-04-08 | 梅迪维新技术公司 | 吡啶并[4,3-b]吲哚类和使用方法 |
WO2011014695A1 (en) | 2009-07-29 | 2011-02-03 | Medivation Technologies, Inc. | New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b] indoles and methods of use |
BR112012006648A2 (pt) | 2009-09-23 | 2019-09-24 | Medivation Neurology Inc | composto,método de tratamento de um distúrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal, composição farmacêutica e kit |
BR112012006646A2 (pt) | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | composto, composição farmacêutica, método de tratamento de um distùrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit |
BR112012006640A2 (pt) * | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | composto, composição farmacêutica, método de tratamento de um distúrbio cognitivo, distúrbiopsocótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit |
JP5791611B2 (ja) | 2009-09-23 | 2015-10-07 | メディベイション テクノロジーズ, インコーポレイテッド | ピリド[3,4−b]インドールおよび使用方法 |
WO2011103487A1 (en) | 2010-02-18 | 2011-08-25 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9034865B2 (en) | 2010-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
WO2011103448A1 (en) | 2010-02-19 | 2011-08-25 | Medivation Technologies, Inc. | Methods and compositions for treating psychotic disorders using antipsychotic combination therapy |
US9187471B2 (en) | 2010-02-19 | 2015-11-17 | Medivation Technologies, Inc. | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
AU2011274787B2 (en) | 2010-07-07 | 2016-06-16 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
WO2012112962A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
US8815843B2 (en) | 2011-02-18 | 2014-08-26 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
WO2012112961A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating hypertension |
US9035056B2 (en) | 2011-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
WO2014031170A1 (en) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
WO2014031167A1 (en) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
AU2012388221B2 (en) | 2012-08-24 | 2017-08-31 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
-
2009
- 2009-03-24 PE PE2009000436A patent/PE20091820A1/es not_active Application Discontinuation
- 2009-03-24 WO PCT/US2009/038142 patent/WO2009120720A1/en active Application Filing
- 2009-03-24 EP EP09725176.3A patent/EP2274307B1/de not_active Not-in-force
- 2009-03-24 BR BRPI0906245-9A patent/BRPI0906245A2/pt not_active IP Right Cessation
- 2009-03-24 US US12/410,425 patent/US8546381B2/en not_active Expired - Fee Related
- 2009-03-24 TW TW098109566A patent/TWI450900B/zh not_active IP Right Cessation
- 2009-03-24 CL CL2009000725A patent/CL2009000725A1/es unknown
- 2009-03-24 AU AU2009228401A patent/AU2009228401B2/en not_active Ceased
- 2009-03-24 CA CA2718790A patent/CA2718790A1/en not_active Abandoned
- 2009-03-24 JP JP2011501990A patent/JP5586577B2/ja not_active Expired - Fee Related
- 2009-03-24 CN CN200980118777.5A patent/CN102046625B/zh not_active Expired - Fee Related
- 2009-03-25 AR ARP090101068A patent/AR071284A1/es unknown
-
2011
- 2011-07-15 HK HK11107367.7A patent/HK1153196A1/xx not_active IP Right Cessation
- 2011-11-03 HK HK11111872.7A patent/HK1157751A1/xx not_active IP Right Cessation
-
2013
- 2013-03-07 US US13/789,606 patent/US9034869B2/en not_active Expired - Fee Related
- 2013-03-08 US US13/791,832 patent/US8999977B2/en not_active Expired - Fee Related
- 2013-09-20 US US14/033,234 patent/US9051314B2/en not_active Expired - Fee Related
-
2014
- 2014-03-11 JP JP2014047700A patent/JP2014111655A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW201000483A (en) | 2010-01-01 |
AR071284A1 (es) | 2010-06-09 |
US9051314B2 (en) | 2015-06-09 |
US8999977B2 (en) | 2015-04-07 |
EP2274307A1 (de) | 2011-01-19 |
US20130184269A1 (en) | 2013-07-18 |
BRPI0906245A2 (pt) | 2015-06-30 |
CN102046625B (zh) | 2015-04-08 |
PE20091820A1 (es) | 2009-12-10 |
AU2009228401A1 (en) | 2009-10-01 |
JP5586577B2 (ja) | 2014-09-10 |
CN102046625A (zh) | 2011-05-04 |
JP2011515483A (ja) | 2011-05-19 |
CL2009000725A1 (es) | 2009-05-29 |
US20130190303A1 (en) | 2013-07-25 |
HK1157751A1 (en) | 2012-07-06 |
US20100099667A1 (en) | 2010-04-22 |
EP2274307B1 (de) | 2015-07-29 |
JP2014111655A (ja) | 2014-06-19 |
TWI450900B (zh) | 2014-09-01 |
CA2718790A1 (en) | 2009-10-01 |
WO2009120720A1 (en) | 2009-10-01 |
US9034869B2 (en) | 2015-05-19 |
US8546381B2 (en) | 2013-10-01 |
AU2009228401B2 (en) | 2014-10-30 |
US20140024643A1 (en) | 2014-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1157751A1 (en) | Bridged heterocyclic compounds and methods of use | |
IL213596A0 (en) | Heterocyclic compounds and methods of use | |
HRP20181370T1 (hr) | Heterociklični spoj i njegova uporaba | |
HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
HRP20190016T1 (hr) | Heterociklički spojevi i njihova upotreba | |
EP2480081A4 (de) | Gebrückte heterocyclische verbindungen und verfahren zu ihrer verwendung | |
HK1172896A1 (zh) | 化合物和使用方法 | |
HK1161094A1 (en) | Compounds and methods of use | |
EP2336105A4 (de) | Stickstoffhaltige heterozyklische verbindung und ihre verwendung | |
EP2361915A4 (de) | Neue heterocyclische verbindung und anwendung davon | |
ZA201005997B (en) | Heterocyclic urea derivatives and methods of use thereof-211 | |
ZA201006505B (en) | Novel heterocyclic compounds and uses thereof | |
EP2264017A4 (de) | Heterocyclisches derivat und seine verwendung | |
ZA201004670B (en) | Fused heterocyclic derivatives and methods of use as c-met inhibitors | |
EP2129677A4 (de) | Heterocyclische cyclopamin-analoga und verfahren zu ihrer verwendung | |
EP2427195A4 (de) | Heterocyclische verbindungen und ihre verwendung | |
EP2192838A4 (de) | Heterocyclische nekroptose-hemmer | |
EP2455380A4 (de) | Heterocyclische verbindung und ihre verwendung | |
EP2242854A4 (de) | Sirna-verbindungen und verfahren zur verwendung davon | |
ZA200905671B (en) | Heterocyclic compounds, compositions comprising them and methods of their use | |
ZA201008609B (en) | Heterocyclic urea derivatives and methods of use thereof | |
IL213695A0 (en) | Adhesive compounds and methods of use thereof | |
EP2399921A4 (de) | Heterocyclische verbindung und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190326 |